The B-cell receptor and ZAP-70 in chronic lymphocytic leukemia.

[1]  J. Byrd,et al.  Nonstochastic pairing of immunoglobulin heavy and light chains expressed by chronic lymphocytic leukemia B cells is predicated on the heavy chain CDR3. , 2005, Blood.

[2]  G. Leone,et al.  ZAP-70 enhances B-cell-receptor signaling despite absent or inefficient tyrosine kinase activation in chronic lymphocytic leukemia and lymphoma B cells. , 2007, Blood.

[3]  F. Lo Coco,et al.  Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. , 2006, Blood.

[4]  M. Karin.  NF‐κB and cancer: Mechanisms and targets , 2006 .

[5]  U. Siebenlist,et al.  NF-κB guides the survival and differentiation of developing lymphocytes , 2006, Cell Death and Differentiation.

[6]  L. Klein-Hitpass,et al.  Lipoprotein lipase expression is a novel prognostic factor in B-cell chronic lymphocytic leukemia , 2006, Leukemia & lymphoma.

[7]  T. Kipps,et al.  ZAP-70 is a novel conditional heat shock protein 90 (Hsp90) client: inhibition of Hsp90 leads to ZAP-70 degradation, apoptosis, and impaired signaling in chronic lymphocytic leukemia. , 2005, Blood.

[8]  L. Rassenti,et al.  ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia. , 2005, Blood.

[9]  R. Dalla‐Favera,et al.  New insights into the phenotype and cell derivation of B cell chronic lymphocytic leukemia. , 2005, Current topics in microbiology and immunology.

[10]  J. Gribben,et al.  Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins. , 2004, Blood.

[11]  Arthur Weiss,et al.  ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia. , 2004, The New England journal of medicine.

[12]  Adrian Wiestner,et al.  ZAP-70 expression and prognosis in chronic lymphocytic leukaemia , 2004, The Lancet.

[13]  Gabriel Núñez,et al.  NF-κB signaling in lymphocytes: a new cast of characters , 2004, Journal of Cell Science.

[14]  M. Schrappe,et al.  Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia , 2003, Nature.

[15]  Emili Montserrat,et al.  ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. , 2003, The New England journal of medicine.

[16]  D. Oscier,et al.  Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia. , 2003, Blood.

[17]  Arthur Weiss,et al.  Expression of ZAP-70 is associated with increased B-cell receptor signaling in chronic lymphocytic leukemia. , 2002, Blood.

[18]  D. Oscier,et al.  The alternative transcript of CD79b is overexpressed in B-CLL and inhibits signaling for apoptosis. , 2002, Blood.

[19]  J. Witkowski,et al.  Modulation of the activity of calcium-activated neutral proteases (calpains) in chronic lymphocytic leukemia (B-CLL) cells. , 2002, Blood.

[20]  R. Aebersold,et al.  The Direct Recruitment of BLNK to Immunoglobulin α Couples the B-Cell Antigen Receptor to Distal Signaling Pathways , 2002, Molecular and Cellular Biology.

[21]  Y. Tu,et al.  Gene Expression Profiling of B Cell Chronic Lymphocytic Leukemia Reveals a Homogeneous Phenotype Related to Memory B Cells , 2001, The Journal of experimental medicine.

[22]  David Botstein,et al.  Relation of Gene Expression Phenotype to Immunoglobulin Mutation Genotype in B Cell Chronic Lymphocytic Leukemia , 2001, The Journal of experimental medicine.

[23]  E. Cesarman,et al.  Survival of leukemic B cells promoted by engagement of the antigen receptor. , 2001, Blood.

[24]  S. Toyabe,et al.  Specific immunoglobulin E responses in ZAP‐70‐deficient patients are mediated by Syk‐dependent T‐cell receptor signalling , 2001, Immunology.

[25]  T. Kurosaki,et al.  Regulation of the phospholipase C‐γ2 pathway in B cells , 2000, Immunological reviews.

[26]  J. Benichou,et al.  Expression of unmutated VH genes is a detrimental prognostic factor in chronic lymphocytic leukemia. , 2000, Blood.

[27]  A. Weiss,et al.  Signal transduction by the TCR for antigen. , 2000, Current opinion in immunology.

[28]  A. A. Thompson,et al.  Aberrant B cell receptor signaling from B29 (Igbeta, CD79b) gene mutations of chronic lymphocytic leukemia B cells. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[29]  T. Kurosaki,et al.  BLNK: connecting Syk and Btk to calcium signals. , 2000, Immunity.

[30]  F. Mandelli,et al.  Analysis of the B-cell receptor B29 (CD79b) gene in familial chronic lymphocytic leukemia. , 1999, Blood.

[31]  T J Hamblin,et al.  Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. , 1999, Blood.

[32]  N. Chiorazzi,et al.  Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. , 1999, Blood.

[33]  Andrew C. Chan,et al.  BLNK Required for Coupling Syk to PLCγ2 and Rac1-JNK in B Cells , 1999 .

[34]  L. Rassenti,et al.  Chronic lymphocytic leukemia B cells express restricted sets of mutated and unmutated antigen receptors. , 1998, The Journal of clinical investigation.

[35]  C. Turck,et al.  BLNK: a central linker protein in B cell activation. , 1998, Immunity.

[36]  T. Kipps.  Signal transduction pathways and mechanisms of apoptosis in CLL B-lymphocytes: their role in CLL pathogenesis. , 1997, Hematology and cell therapy.

[37]  V. Lang,et al.  Normal Syk protein level but abnormal tyrosine phosphorylation in B-CLL cells , 1997, Leukemia.

[38]  A. A. Thompson,et al.  Aberrations of the B-cell receptor B29 (CD79b) gene in chronic lymphocytic leukemia. , 1997, Blood.

[39]  A. Weiss,et al.  T cell antigen receptor signal transduction. , 1997, Current opinion in cell biology.

[40]  J. Brugge,et al.  Protein tyrosine kinases Syk and ZAP-70 display distinct requirements for Src family kinases in immune response receptor signal transduction. , 1997, Journal of immunology.

[41]  L. Rassenti,et al.  Ig VH1 genes expressed in B cell chronic lymphocytic leukemia exhibit distinctive molecular features. , 1997, Journal of immunology.

[42]  A. Veillette,et al.  Differential Intrinsic Enzymatic Activity of Syk and Zap-70 Protein-tyrosine Kinases* , 1996, The Journal of Biological Chemistry.

[43]  C. Schoot,et al.  Antigen receptor nonresponsiveness in chronic lymphocytic leukemia B cells , 1995 .

[44]  T. Kurosaki,et al.  Reconstitution of Syk function by the ZAP-70 protein tyrosine kinase. , 1995, Immunity.

[45]  N. Chiorazzi,et al.  Somatic diversification and selection of immunoglobulin heavy and light chain variable region genes in IgG+ CD5+ chronic lymphocytic leukemia B cells , 1995, The Journal of experimental medicine.

[46]  A. Weiss,et al.  Differential expression of ZAP-70 and Syk protein tyrosine kinases, and the role of this family of protein tyrosine kinases in TCR signaling. , 1994, Journal of immunology.

[47]  C. Disteche,et al.  Molecular cloning of human Syk. A B cell protein-tyrosine kinase associated with the surface immunoglobulin M-B cell receptor complex. , 1994, The Journal of biological chemistry.

[48]  P. Debré,et al.  Defective calcium response in B-chronic lymphocytic leukemia cells. Alteration of early protein tyrosine phosphorylation and of the mechanism responsible for cell calcium influx. , 1993, Journal of immunology.

[49]  Arthur Weiss,et al.  ZAP-70: A 70 kd protein-tyrosine kinase that associates with the TCR ζ chain , 1992, Cell.

[50]  L. Rassenti,et al.  Immunoglobulin V Gene Expression in CD5 B‐Cell Malignancies a , 1992, Annals of the New York Academy of Sciences.

[51]  H. Nakamura,et al.  Molecular cloning of a porcine gene syk that encodes a 72-kDa protein-tyrosine kinase showing high susceptibility to proteolysis. , 1991, The Journal of biological chemistry.

[52]  C. Hivroz,et al.  Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2 , 1986, European journal of immunology.